SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cresanto Global informs about newspaper publication

30 May 2026 Evaluate
In terms of Regulation 30 and Regulation 47(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), Cresanto Global has attached newspaper cuttings of the advertisement in relation to the Standalone Audited Financial Results of the Company for the Fourth quarter and Financial year ended on 31st March, 2026 as specified in Regulation 33 of LODR published in Business Standard (English) and Business Standard (Hindi) on 29th May, 2026 and the same is also being displayed on the website of the Company viz. www.raymedlab.com. Kindly take the same on your records.

The above information is a part of company’s filings submitted to BSE. 

Cresanto Global Share Price

4.65 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.10
Dr. Reddys Lab 1266.60
Cipla 1380.90
Zydus Lifesciences 1107.00
Lupin 2270.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×